Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes

American Journal of Hypertension

Volumn 16, Issue 7, 2003, Pages 600-603

  Brands, Michael W ^a   Cloud, Leslie J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Diabetes; Hypertension; Nitric oxide; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ENALAPRIL; MERCURY; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; STREPTOZOCIN;

ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CLAMP; CONTROLLED STUDY; DIABETES MELLITUS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ONSET AGE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0037560301     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00902-6     Document Type: Article

References (12)

1. Fitzgerald SM, Brands MW: Nitric oxide may be required to prevent hypertension at the onset of diabetes. Am J Physiol Endocrinol Metab 2000;279:E762-E768.
2. Fitzgerald SM, Brands MW: Hypertension in L-NAME treated diabetic rats depends on an intact sympathetic nervous system. Am J Physiol Regul Integr Comp Physiol 2002;282:R1070-R1076.
3. Brands MW, Fitzgerald SM: Acute endothelium-mediated vasodilation is not impaired at the onset of diabetes. Hypertension 1998;32:541-547.
4. Brands MW, Fitzgerald SM, Hewitt WH, Hailman AE: Decreased cardiac output at the onset of diabetes: Renal mechanisms and peripheral vasoconstriction. Am J Physiol 2000;278:E917-E924.
5. Claxton CR, Brands MW, Fitzgerald SM, Cameron JA: Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats. Hypertension 2000;35:451-456.
6. Lansang MC, Price DA, Laffel LM, Osei SY, Fisher ND, Erani D, Hollenberg NK: Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 2001;59:1432-1438.
7. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, Shigeta Y: Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Ren Physiol 1986;9:187-192.
8. Miller JA: Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 1999;10:1778-1785.
9. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG: Effect of hyperglycemia on arterial pressure, plasma renin activity, and renal function in early diabetes. Clin Sci 1996;90:189-195.
10. Lansang MC, Hollenberg NK: Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: Are the forces leading to vasodilation and vasoconstriction linked? Diabetes 2002;51:2025-2028.
11. Woods LL, Mizelle HL, Hall JE: Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol 1987;252:F65-F71.
12. Balaszczuk AM, Tomat A, Bellucci S, Fellet A, Arranz C: Nitric oxide synthase blockade and body fluid volumes. Braz J Med Biol Res 2002;35:131-134.